FDA Application
-
NDC Search Results on Active Ingredient: Diclofenac
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
CALCIPOTRIENE; NIACINAMIDE; DICLOFENAC SODIUM; HYALURONATE SODIUM | 72934-2030-2 | Sincerus Florida, LLC | HUMAN PRESCRIPTION DRUG | unapproved drug other | |
DICLOFENAC SODIUM; CAPSAICIN | 73247-201-01 | Bodysphere, LLC | ANDA204132 | HUMAN PRESCRIPTION DRUG | ANDA |
MENTHOL; DICLOFENAC SODIUM | 73272-301-01 | Upstream Pharma, LLC | ANDA203818 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC POTASSIUM | 73352-086-30 | Trifluent Pharma LLC | ANDA075229 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC POTASSIUM | 73352-086-60 | Trifluent Pharma LLC | ANDA075229 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC POTASSIUM | 73352-095-60 | Trifluent Pharma LLC | ANDA210078 | HUMAN PRESCRIPTION DRUG | ANDA |
LIDOCAINE; MENTHOL, (+)-; DICLOFENAC SODIUM | 73352-565-01 | Trifluent Pharma LLC | M017 | HUMAN OTC DRUG | OTC Monograph Drug |
DICLOFENAC SODIUM | 73377-113-01 | AX Pharmaceutical Corp | BULK INGREDIENT | bulk ingredient for animal drug compounding | |
DICLOFENAC SODIUM | 73469-2053-1 | Scholl's Wellness Company | ANDA208077 | HUMAN OTC DRUG | ANDA |
DICLOFENAC SODIUM | 73469-2053-8 | Scholl's Wellness Company | ANDA208077 | HUMAN OTC DRUG | ANDA |
DICLOFENAC SODIUM | 73516-450-01 | Ashoka Health | ANDA204132 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC SODIUM; CAPSAICIN | 73516-801-01 | Ashoka Health | ANDA204132 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC SODIUM | 73581-104-15 | YYBA CORP | ANDA210986 | HUMAN OTC DRUG | ANDA |
DICLOFENAC POTASSIUM | 73684-150-60 | BLUCREST PHARMACEUTICALS, LLC | ANDA076561 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC SODIUM | 73715-005-01 | Mohnark Pharmaceuticals Inc. | ANDA210986 | HUMAN OTC DRUG | ANDA |
DICLOFENAC POTASSIUM | 74157-007-60 | INA Pharmaceutics Inc | ANDA075229 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC POTASSIUM | 74157-095-60 | INA Pharmaceutics Inc. | ANDA210078 | HUMAN PRESCRIPTION DRUG | ANDA |
MISOPROSTOL; DICLOFENAC SODIUM | 75834-264-60 | Nivagen Pharmaceuticals, Inc. | ANDA205143 | HUMAN PRESCRIPTION DRUG | ANDA |
MISOPROSTOL; DICLOFENAC SODIUM | 75834-264-90 | Nivagen Pharmaceuticals, Inc. | ANDA205143 | HUMAN PRESCRIPTION DRUG | ANDA |
MISOPROSTOL; DICLOFENAC SODIUM | 75834-265-60 | Nivagen Pharmaceuticals, Inc. | ANDA205143 | HUMAN PRESCRIPTION DRUG | ANDA |
CAPSICUM OLEORESIN; OMEPRAZOLE; DICLOFENAC SODIUM | 75840-094-01 | GenPak Solutions, LLC | ANDA077863 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC SODIUM; CAPSICUM OLEORESIN | 75840-095-01 | GenPak Solutions, LLC | ANDA077863 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC SODIUM | 75987-040-05 | Horizon Therapeutics USA, Inc. | NDA204623 | HUMAN PRESCRIPTION DRUG | NDA |
DICLOFENAC SODIUM | 75987-040-74 | Horizon Therapeutics USA, Inc. | NDA204623 | HUMAN PRESCRIPTION DRUG | NDA |
DICLOFENAC SODIUM | 75987-040-75 | Horizon Therapeutics USA, Inc. | NDA204623 | HUMAN PRESCRIPTION DRUG | NDA |
DICLOFENAC SODIUM | 76074-501-11 | Two Hip Consulting, LLC | HUMAN PRESCRIPTION DRUG | unapproved drug other | |
DICLOFENAC SODIUM | 76282-663-39 | EXELAN PHARMACEUTICALS INC. | ANDA209903 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC SODIUM | 76420-012-30 | Asclemed USA, Inc. | ANDA206116 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC SODIUM | 76420-025-01 | Asclemed USA, Inc. | ANDA200936 | HUMAN PRESCRIPTION DRUG | ANDA |
DICLOFENAC SODIUM | 76420-091-01 | Asclemed USA, Inc. | ANDA210986 | HUMAN PRESCRIPTION DRUG | ANDA |
-